Eva Tloušťová

700 total citations
40 papers, 592 citations indexed

About

Eva Tloušťová is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Eva Tloušťová has authored 40 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 19 papers in Infectious Diseases and 10 papers in Organic Chemistry. Recurrent topics in Eva Tloušťová's work include HIV/AIDS drug development and treatment (17 papers), Biochemical and Molecular Research (16 papers) and Click Chemistry and Applications (4 papers). Eva Tloušťová is often cited by papers focused on HIV/AIDS drug development and treatment (17 papers), Biochemical and Molecular Research (16 papers) and Click Chemistry and Applications (4 papers). Eva Tloušťová collaborates with scholars based in Czechia, United States and Austria. Eva Tloušťová's co-authors include Ivan Votruba, Antonı́n Holý, Milena Masojı́dková, Michal Hocek, Petr Džubák, Marián Hajdúch, Helena Mertlíková‐Kaiserová, Lenka Poštová Slavětínská, Pavla Perlíková and Michal Tichý and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Eva Tloušťová

39 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Tloušťová Czechia 16 328 253 216 123 52 40 592
Pavla Perlíková Czechia 17 464 1.4× 295 1.2× 225 1.0× 120 1.0× 62 1.2× 30 713
Domenico Tarantino Italy 13 267 0.8× 202 0.8× 135 0.6× 144 1.2× 60 1.2× 21 624
Ugo Pradère France 11 389 1.2× 447 1.8× 294 1.4× 113 0.9× 27 0.5× 13 767
Canio J. Marasco United States 13 390 1.2× 103 0.4× 85 0.4× 81 0.7× 35 0.7× 18 558
В. Л. Андронова Russia 13 142 0.4× 140 0.6× 105 0.5× 165 1.3× 15 0.3× 68 427
Laurence Dugué France 13 304 0.9× 100 0.4× 136 0.6× 59 0.5× 27 0.5× 22 376
Marco Derudas United Kingdom 16 208 0.6× 137 0.5× 255 1.2× 180 1.5× 18 0.3× 28 588
Masakatsu Kaneko Japan 17 805 2.5× 259 1.0× 173 0.8× 77 0.6× 52 1.0× 61 1.0k
Christine Burlein United States 11 184 0.6× 144 0.6× 182 0.8× 98 0.8× 10 0.2× 18 449
Maria Tardugno Italy 9 384 1.2× 96 0.4× 48 0.2× 57 0.5× 30 0.6× 10 582

Countries citing papers authored by Eva Tloušťová

Since Specialization
Citations

This map shows the geographic impact of Eva Tloušťová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Tloušťová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Tloušťová more than expected).

Fields of papers citing papers by Eva Tloušťová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Tloušťová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Tloušťová. The network helps show where Eva Tloušťová may publish in the future.

Co-authorship network of co-authors of Eva Tloušťová

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Tloušťová. A scholar is included among the top collaborators of Eva Tloušťová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Tloušťová. Eva Tloušťová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Česnek, Michal, Jaroslav Kozák, Eva Tloušťová, et al.. (2024). Structure-Based Drug Design of ADRA2A Antagonists Derived from Yohimbine. Journal of Medicinal Chemistry. 67(12). 10135–10151. 3 indexed citations
2.
Dzijak, Rastislav, Martin Dračínský, Paul E. Reyes‐Gutiérrez, et al.. (2024). Sulfonated Hydroxyaryl‐Tetrazines with Increased pKa for Accelerated Bioorthogonal Click‐to‐Release Reactions in Cells. Angewandte Chemie. 137(5).
3.
Česnek, Michal, et al.. (2023). Discovery of a potent and selective human AC2 inhibitor based on 7-deazapurine analogues of adefovir. Bioorganic & Medicinal Chemistry. 95. 117508–117508. 2 indexed citations
4.
Doleželová, Eva, et al.. (2022). Synthesis and anti-trypanosomal evaluation of novel N-branched acyclic nucleoside phosphonates bearing 7-aryl-7-deazapurine nucleobase. European Journal of Medicinal Chemistry. 239. 114559–114559. 2 indexed citations
5.
Česnek, Michal, Martin Dračínský, Eva Tloušťová, et al.. (2021). Halogen‐Dance‐Based Synthesis of Phosphonomethoxyethyl (PME) Substituted 2‐Aminothiazoles as Potent Inhibitors of Bacterial Adenylate Cyclases. ChemMedChem. 17(1). e202100568–e202100568. 4 indexed citations
6.
Pohl, Radek, Eva Tloušťová, Soňa Gurská, et al.. (2020). Pyrido-Fused Deazapurine Bases: Synthesis and Glycosylation of 4-Substituted 9H-Pyrido[2′,3′:4,5]- and Pyrido[4′,3′:4,5]pyrrolo[2,3-d]pyrimidines. ACS Omega. 5(40). 26278–26286. 1 indexed citations
7.
Procházková, Eliška, Hubert Hřebabecký, Milan Dejmek, et al.. (2019). Could 5′-N and S ProTide analogues work as prodrugs of antiviral agents?. Bioorganic & Medicinal Chemistry Letters. 30(4). 126897–126897. 5 indexed citations
8.
Lišková, Barbora, Michal Tichý, Soňa Gurská, et al.. (2018). Synthesis and Cytotoxic and Antiviral Profiling of Pyrrolo- and Furo-Fused 7-Deazapurine Ribonucleosides. Journal of Medicinal Chemistry. 61(20). 9347–9359. 22 indexed citations
9.
Perlíková, Pavla, Chao Yang, Radek Pohl, et al.. (2018). Isomeric Naphtho‐Fused 7‐Deazapurine Nucleosides and Nucleotides: Synthesis, Biological Activity, Photophysical Properties and Enzymatic Incorporation to Nucleic Acids. European Journal of Organic Chemistry. 2018(37). 5092–5108. 10 indexed citations
10.
11.
Perlíková, Pavla, Petr Nauš, Tomáš Elbert, et al.. (2016). 7-(2-Thienyl)-7-Deazaadenosine (AB61), a New Potent Nucleoside Cytostatic with a Complex Mode of Action. Molecular Cancer Therapeutics. 15(5). 922–937. 27 indexed citations
12.
Slavı́ková, Barbora, Eva Tloušťová, Vojtěch Vyklický, et al.. (2016). Physicochemical and biological properties of novel amide-based steroidal inhibitors of NMDA receptors. Steroids. 117. 52–61. 23 indexed citations
13.
Nauš, Petr, Pavla Perlíková, Lenka Poštová Slavětínská, et al.. (2015). Synthesis and biological profiling of 6- or 7-(het)aryl-7-deazapurine 4′-C-methylribonucleosides. Bioorganic & Medicinal Chemistry. 23(23). 7422–7438. 15 indexed citations
14.
Hřebabecký, Hubert, Eliška Procházková, Michal Šála, et al.. (2015). Synthesis and biological evaluation of conformationally restricted adenine bicycloribonucleosides. Organic & Biomolecular Chemistry. 13(35). 9300–9313. 10 indexed citations
15.
Tichý, Michal, Radek Pohl, Eva Tloušťová, et al.. (2013). Synthesis and biological activity of benzo-fused 7-deazaadenosine analogues. 5- and 6-substituted 4-amino- or 4-alkylpyrimido[4,5-b]indole ribonucleosides. Bioorganic & Medicinal Chemistry. 21(17). 5362–5372. 24 indexed citations
16.
17.
Mertlíková‐Kaiserová, Helena, Michaela Rumlová, Eva Tloušťová, et al.. (2011). Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG. Biochemical Pharmacology. 82(2). 131–138. 5 indexed citations
18.
Hájek, Miroslav, et al.. (2005). Inhibition of human telomerase by diphosphates of acyclic nucleoside phosphonates. Biochemical Pharmacology. 70(6). 894–900. 24 indexed citations
19.
Votruba, Ivan, et al.. (2005). Inhibition of thymidine phosphorylase (PD-ECGF) from SD-lymphoma by phosphonomethoxyalkyl thymines. Biochemical Pharmacology. 69(10). 1517–1521. 23 indexed citations
20.
Nencka, Radim, Ivan Votruba, Hubert Hřebabecký, et al.. (2005). Design and synthesis of novel 5,6-disubstituted uracil derivatives as potent inhibitors of thymidine phosphorylase. Bioorganic & Medicinal Chemistry Letters. 16(5). 1335–1337. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pavla Perlíková Breakdown of academic impact, for papers by Domenico Tarantino Breakdown of academic impact, for papers by Ugo Pradère Breakdown of academic impact, for papers by Canio J. Marasco Breakdown of academic impact, for papers by В. Л. Андронова Breakdown of academic impact, for papers by Laurence Dugué Breakdown of academic impact, for papers by Marco Derudas Breakdown of academic impact, for papers by Masakatsu Kaneko Breakdown of academic impact, for papers by Christine Burlein Breakdown of academic impact, for papers by Maria Tardugno
Rankless by CCL
2026